Company Profile
About Us
Your transparent partner in biomanufacturing and ingredient supply.
Facilities & Expertise
Morika Bio is an established ingredient manufacturer headquartered in Qingdao, China. Focusing on precision fermentation for Salidroside and HMO ingredients, we operate with an engineer's mindset: quality control, stable supply, and strict adherence to technical specifications.
We do not aggressively market consumer health claims; instead, we provide R&D and procurement teams worldwide with the reliable raw materials they need to build successful brands.
Our Principle
Provide uncompromised raw materials with clear, verifiable technical data.
Our Capability
Operate stable, scalable biomanufacturing lines that solve supply chain instability for our clients.
Our Journey
Innovation Milestones
A decade of pioneering precision fermentation and redefining bio-active ingredient safety standards.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
Production & Quality System Upgrade
Standardized key production and quality-control workflows to improve batch consistency and delivery reliability.
Production & Quality System Upgrade
Standardized key production and quality-control workflows to improve batch consistency and delivery reliability.
LNTr II Milestone — FDA GRAS Notification Completed
Completed the FDA GRAS notification for LNTr II (Lacto-N-Triose II), further strengthening the safety and regulatory foundation for next-generation HMOs.
LNTr II Milestone — FDA GRAS Notification Completed
Completed the FDA GRAS notification for LNTr II (Lacto-N-Triose II), further strengthening the safety and regulatory foundation for next-generation HMOs.
Full Product Portfolio Launched
Focused the commercial portfolio around HMO variants and Salidroside product lines. Strengthened FSSC 22000, Halal, and GMP certifications across manufacturing. FDA GRAS and EU Novel Food milestones continued on applicable HMO platforms.
Full Product Portfolio Launched
Focused the commercial portfolio around HMO variants and Salidroside product lines. Strengthened FSSC 22000, Halal, and GMP certifications across manufacturing. FDA GRAS and EU Novel Food milestones continued on applicable HMO platforms.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.